Antitumor effect of secreted Flt3-ligand can act at distant tumor sites in a murine model of head and neck cancer (original) (raw)
Fearon E, Pardoll D, Itaya T, et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an anti-tumor response. Cell. 1990;60:397–403. ArticleCASPubMed Google Scholar
Armstrong CA, Botella R, Galloway TH, et al. Anti-tumor effects of granulocyte–macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 1996;56:2191–2198. CASPubMed Google Scholar
Chen SH, Chen XHL, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci. 1995;92:2577–2581. ArticleCASPubMedPubMed Central Google Scholar
Seong JY, Dae SH, Jung OK, et al. Synergistic anti-tumor effects with co-expression of GM-CSF and IFN-r in murine tumors. Int J Cancer. 1998;77:907–912. Article Google Scholar
Goolee S, Heo DS, Yoon SJ, et al. Effect of GM-CSF and IL-2 coexpression on the anti-tumor immune response. Anticancer Res. 2000;20:2681–2686. Google Scholar
Felzmann T, Ramsey WJ, Blaese RM . Characterization of the anti-tumor immune response generated by treatment of murine tumor with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1. Gene Ther. 1997;4:1322–1329. ArticleCASPubMed Google Scholar
Allione A, Consalvo M, Nanni P, et al. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin IL-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte–macrophage colony-stimulating factor, and gamma interferon gene or admixed with conventional adjuvants. Cancer Res. 1994;54:6022–6026. CASPubMed Google Scholar
Cheng YC, Grill SP, Dutschman GE, et al. Metabolism of 9-(1,3-dihydroxy-2-2 propoxymethyl) guanine, a new anti-herpes virus compound in herpes simplex virus–infected cells. J Biol Chem. 1983;258:12460–12464. CASPubMed Google Scholar
Bi WL, Parysek LM, Warnick R, et al. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther. 1993;4:725–731. ArticleCASPubMed Google Scholar
Freeman SM, Abboud CN, Whartenby KA, et al. The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274–5283. CASPubMed Google Scholar
Elshami AA, Saavedra A, Zhang H, et al. Gap junctions play a role in the “bystander effect” of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 1996;3:85–92. CASPubMed Google Scholar
Wygoda MR, Wilson MR, Davis MA, et al. Protection of herpes simplex virus thymidine kinase–transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect. Cancer Res. 1977;57:1699–1703. Google Scholar
Kim YG, Bi WL, Feliciano ES, et al. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene. Cancer Gene Ther. 2000;7:240–246. ArticleCASPubMed Google Scholar
Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood. 1994;83:2795–2801. CASPubMed Google Scholar
Hannum C, Culpepper J, Campbell D, et al. Ligand for flt4/flk2 receptor regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature. 1994;368:643–648. ArticleCASPubMed Google Scholar
Lyman SD, Brasel K, Escobar SS, et al. Identification of a soluble and membrane bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene. 1995;10:149–159. CASPubMed Google Scholar
Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996;184:1953–1962. ArticleCASPubMed Google Scholar
Steptoe RJ, Fu F, Li W, et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immun. 1997;159:5438–5491. Google Scholar
Chen K, Braun S, Lyman S, et al. Anti-tumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 1997;57:3511–3516. CASPubMed Google Scholar
Lynch DH, Andreasen A, Maraskovsky C, et al. Flt3 ligand induces tumor regression and anti-tumor immune response in vivo. Nat Med. 1997;3:625–631. ArticleCASPubMed Google Scholar
Esche C, Subbotin VM, Maliszewski C, et al. Flt3-ligand administration inhibit tumor regression growth in murine melanoma and lymphoma. Cancer Res. 1998;58:380–383. CASPubMed Google Scholar
American Cancer Society. Facts and Figures. Washington, DC: American Cancer Society; 2000.
Landis SH, Murray T, Bolden S, et al. Cancer statistics. Cancer J Clin. 1998;1:6–29. Article Google Scholar
Day KV, Li D, Liu S, et al. Granulocyte–macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer. Laryngoscope. 2001;111:801–806. ArticleCASPubMed Google Scholar
O'Malley BW, Chen SH, Schwartz MR, et al. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 1995;55:1080–1085. CASPubMed Google Scholar
Bi WL, Kim YG, Feliciano ES, et al. An HSVtk-mediated local and distant anti-tumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther. 1997;4:246–252. CASPubMed Google Scholar
Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector–producer cells for treatment of experimental brain tumors. Science (Washington, DC). 1992;256:1550–1552. ArticleCAS Google Scholar
Ram Z, Culver KW, Walbridge S, et al. In situ retroviral-mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther. 1993;53:83–88. CAS Google Scholar
Kianmanesh AR, Perrin H, Panis Y, et al. A “Distant” bystander effect of suicide gene therapy regression of nontransduced tumor together with a distance transduced tumor. Hum Gene Ther. 1997;8:1807–1814. ArticleCASPubMed Google Scholar
Agard C, Ligeza C, Dupas B, et al. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Cancer Gene Ther. 2001;8:128–136. ArticleCASPubMed Google Scholar
Wilson KM, Stambrook PJ, Bi WL, et al. HSV-tk gene therapy in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1996;122:746–749. ArticleCASPubMed Google Scholar
Lyman SD, Brasel K, Rousseau AM, et al. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells. 1994;12:99–107. PubMed Google Scholar
Small D, Levenseein M, Kim E, et al. The human homolog of flt2.flt3, is selectively expressed in CD34 human bone marrow cells and is involved in proliferation of early progenitory stem cells. Proc Natl Acad Sci. 1994;91:459–463. ArticleCASPubMedPubMed Central Google Scholar
Rosenet O, Schiff C, Pebusque MJ, et al. Human filt3/flt2 gene: cDNA cloning and expression in hematopoietic cells. Blood. 1993;82:1110–1119. Google Scholar
Qiao J, Blacb ME, Caruso M . Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. Hum Gene Ther. 2000;11:1569–1576. ArticleCASPubMed Google Scholar
Chen CY, Chang YN, Ryan P, et al. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the “bystander effect”. Hum Gene Ther. 1995;6:1467–1476. ArticleCASPubMed Google Scholar
Chen SH, Kosai K, Xu B, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained anti-tumor immunity prolongs animal survival. Cancer Res. 1996;15:3758–3762. Google Scholar
Freund CT, Sutton MA, Dong T, et al. Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 2000;20:1359–1365. CASPubMed Google Scholar
Toda M, Martuza RI, Rabkin SD . Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus–based cancer vaccine. Gene Ther. 2001;8:332–339. ArticleCASPubMed Google Scholar
Mesnil M, Yamasaki H . Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000;60:3989–3999. CASPubMed Google Scholar
Wei MX, Bougnoux P, Sacre-salem B, et al. Suicide gene therapy of chemically induce mammary tumor in rat: efficacy and distant bystander effect. Cancer Res. 1998;58:3529–3532. CASPubMed Google Scholar
Engelmann C, Heslan JM, Fabre M, et al. Importance mechanisms and limitations of the distant bystander effect in cancer gene therapy of experimental liver tumors. Cancer Lett. 2002;179:59–69. ArticleCASPubMed Google Scholar
Suan J, Michael A . The clinical problem and immuno-modulation. In: Habib NA, ed Cancer Gene Therapy: Past Achievements and Future Challenges. 1st ed. New York: Kluwer Academic Publishing/Plenum; 1999:292–293. Google Scholar
Liau LM, Black KL, Prins RM, et al. Treatment of intracranial gliomas with bone marrow–derived dendritic cells pulsed with tumor antigens. J Neurosurg. 1999;90:1115–1124. ArticleCASPubMed Google Scholar
Nouri-Shirazi M, Banchereau J, Bell D, et al. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol. 2000;165:3797–3803. ArticleCASPubMed Google Scholar
Braun SE, Chen K, Balzar BR, et al. Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte–macrophage colony-stimulating factor and a potential mechanism of action. Hum Gene Ther. 1999;10:2141–2151. ArticleCASPubMed Google Scholar
Von Eckardstein KL, Patt S, Zhu J, et al. Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors. Histol Histopathol. 2001;16:735–744. CASPubMed Google Scholar